These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31528121)

  • 1. Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.
    Ma W; Wang B; Zhang Y; Wang Z; Niu D; Chen S; Zhang Z; Shen N; Han W; Zhang X; Wei R; Wang C
    Cancer Cell Int; 2019; 19():239. PubMed ID: 31528121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
    Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
    Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
    Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
    Front Genet; 2018; 9():469. PubMed ID: 30369945
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
    Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
    Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
    Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
    Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
    Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
    [No Abstract]   [Full Text] [Related]  

  • 10. IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma.
    Wei R; Qi G; Zeng Z; Shen N; Wang Z; Shen H; Gao L; Song C; Ma W; Wang C
    Cancer Cell Int; 2021 Nov; 21(1):620. PubMed ID: 34819098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
    Chen W; Zhu S; Zhang Y; Xiao J; Tian D
    Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.
    Zhang J; Li D; Zhang Y; Ding Z; Zheng Y; Chen S; Wan Y
    Oncol Rep; 2020 Jan; 43(1):99-112. PubMed ID: 31746439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed genes in non-small cell lung cancer.
    Wang K; Chen R; Feng Z; Zhu YM; Sun XX; Huang W; Chen ZN
    Aging (Albany NY); 2019 Dec; 11(23):11170-11185. PubMed ID: 31816603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis to determine the prognostic value and prospective pathway signaling of miR-126 in non-small cell lung cancer.
    Jiao Z; Yu A; He X; Xuan Y; Zhang H; Wang G; Shi M; Wang T
    Ann Transl Med; 2020 Dec; 8(24):1639. PubMed ID: 33490151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.
    Wu Q; Zhang B; Sun Y; Xu R; Hu X; Ren S; Ma Q; Chen C; Shu J; Qi F; He T; Wang W; Wang Z
    Onco Targets Ther; 2019; 12():3545-3563. PubMed ID: 31190860
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
    Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
    J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer.
    Zeng Y; Shi Y; Xu L; Zeng Y; Cui X; Wang Y; Yang N; Zhou F; Zhou Y
    Front Oncol; 2021; 11():656172. PubMed ID: 34026630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.
    Meng J; Wei Y; Deng Q; Li L; Li X
    Cancer Cell Int; 2022 Jan; 22(1):29. PubMed ID: 35033076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.